Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
DSP Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesCipla Limited8.86181790481262.4308
Domestic EquitiesCohance Lifesciences Limited8.80772489539260.8290
Domestic EquitiesSun Pharmaceutical Industries Limited8.69911535592257.6109
Domestic EquitiesIPCA Laboratories Limited8.16181696381241.7004
Domestic EquitiesGland Pharma Limited4.9389920673146.2581
Domestic EquitiesAlembic Pharmaceuticals Limited4.90981428180145.3959
Domestic EquitiesLaurus Labs Limited4.56552217884135.2022
Domestic EquitiesApollo Hospitals Enterprise Limited4.5253194767134.0094
Domestic EquitiesSai Life Sciences Limited4.08231597108120.8931
Domestic EquitiesPfizer Limited3.8032200644112.6275
Domestic EquitiesKovai Medical Center and Hospital Limited3.4482165156102.1151
Domestic EquitiesProcter & Gamble Health Limited3.080415870491.2231
Domestic EquitiesVijaya Diagnostic Centre Limited3.021193553089.4647
Domestic EquitiesConcord Biotech Limited2.891848977485.6370
Domestic EquitiesIndoco Remedies Limited2.7371323347481.0567
Domestic EquitiesUnichem Laboratories Limited1.721285206350.9704
Domestic EquitiesEmcure Pharmaceuticals Limited1.539434277645.5858
Domestic EquitiesICICI Lombard General Insurance Company Limited1.528824141345.2746
Domestic EquitiesAarti Drugs Limited1.277285215537.8229
Domestic EquitiesNarayana Hrudayalaya Ltd.0.815413846524.1469
Domestic EquitiesThyrocare Technologies Limited0.811622906424.0334
Domestic EquitiesAlkem Laboratories Limited0.64283733419.0347
Domestic EquitiesMedplus Health Services Limited0.626819207818.5624
Domestic EquitiesJupiter Life Line Hospitals Limited0.46559411713.7863
Domestic EquitiesLaxmi Dental Limited0.363428040110.7604
Total 86.3262 2556.4317
Cash & Cash Equivalents and Net AssetsTREPS / Reverse Repo Investments0.6024 17.8390
Cash & Cash Equivalents and Net AssetsNet Receivables/Payables-0.1846 -5.4663
Total 0.4178 12.3727
Overseas EquitiesGlobus Medical Inc4.5916268800135.9739
Overseas EquitiesIllumina Inc3.8076160400112.7558
Overseas EquitiesIntuitive Surgical Inc2.99221876888.6086
Overseas EquitiesAbbott Laboratories1.21843160036.0811
Overseas EquitiesGrail Inc0.096887332.8672
Total 12.7065 376.2866
Overseas Mutual Fund UnitsGlobal X Funds - Global X Genomics & Biotechnology ETF0.549524500016.2719
Total 0.5495 16.2719
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.